PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals

Nature Medicine

Volumn 22, Issue 7, 2016, Pages 754-761

  Banga, Riddhima ^a   Procopio, Francesco Andrea ^a   Noto, Alessandra ^a   Pollakis, Georgios ^b   Cavassini, Matthias ^a   Ohmiti, Khalid ^a   Corpataux, Jean Marc ^a   De Leval, Laurence ^a   Pantaleo, Giuseppe ^a   Perreau, Matthieu ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR5; DOLUTEGRVIR; EFAVIRENZ; ELVITEGRAVIR; EMTRICITABINE; ETRAVIRINE; LAMIVUDINE; LOPINAVIR; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; RALTEGRAVIR; RITONAVIR; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG; ZIDOVUDINE; CXCR5 PROTEIN, HUMAN; PDCD1 PROTEIN, HUMAN; VIRUS RNA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL POPULATION; COMPARATIVE STUDY; DISEASE DURATION; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CASE CONTROL STUDY; CYTOLOGY; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; LYMPH NODE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CXCR5; RNA, VIRAL; T-LYMPHOCYTES, HELPER-INDUCER; VIRUS REPLICATION;

EID: 84973131619     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4113     Document Type: Article

References (29)

1. Chun, T.W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94, 13193-13197 (1997).
2. Chun, T.W. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188 (1997).
3. Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300 (1997).
4. Wong, J.K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278, 1291-1295 (1997).
5. Siliciano, J.D. et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9, 727-728 (2003).
6. Chomont, N. et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15, 893-900 (2009).
7. Buzon, M.J. et al. HIV-1 persistence in CD4+ T cells with stem-cell-like properties. Nat. Med. 20, 139-142 (2014).
8. Kim, C.H. et al. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal-center-localized subset of CXCR5+ T cells. J. Exp. Med. 193, 1373-1381 (2001).
9. Breitfeld, D. et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles and support immunoglobulin production. J. Exp. Med. 192, 1545-1552 (2000).
10. Schaerli, P. et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192, 1553-1562 (2000).
11. Perreau, M. et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication and production. J. Exp. Med. 210, 143-156 (2013).
12. Fukazawa, Y. et al. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat. Med. 21, 132-139 (2015).
13. Fletcher, C.V. et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl. Acad. Sci. USA 111, 2307-2312 (2014).
14. Casazza, J.P.I. et al. Identification and characterization of individual HIV-infected CD4 T cells ex vivo. (Conference on Retroviruses and Opportunistic Infections, Seattle, abstract no. 49) (International Antiviral Society-USA, San Francisco, California, USA, 2015).
15. Locci, M. et al. Human circulating PD-1+CXCR3-CXCR5+ memory TFH cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758-769 (2013).
16. Morita, R. et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108-121 (2011).
17. Banga, R., Procopio, F.A., Cavassini, M. and Perreau, M. In vitro reactivation of replication-competent and infectious HIV-1 by histone deacetylase inhibitors. J. Virol. 90, 1858-1871 (2015).
18. Hu, Y. and Smyth, G.K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70-78 (2009).
19. Sobolewski, M.C.A., Lalama, C., Bosch, R. and Mellors, J. A rapid virion-recovery assay reveals a larger population of inducible proviruses in resting CD4+ T cells than previously recognized. (Conference on Retroviruses and Opportunistic Infections, Atlanta, abstract no. 174LB) (International Antiviral Society-USA, San Francisco, California, USA, 2013).
20. Bullen, C.K., Laird, G.M., Durand, C.M., Siliciano, J.D. and Siliciano, R.F. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat. Med. 20, 425-429 (2014).
21. Ganusov, V.V. and De Boer, R.J. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 28, 514-518 (2007).
22. Procopio, F.A. et al. A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals. EBioMedicine 2, 872-881 (2015).
23. Vandergeeten, C. et al. Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies. J. Virol. 88, 12385-12396 (2014).
24. Lorenzo-Redondo, R. et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530, 51-56 (2016).
25. Altman, D.G. Practical Statistics for Medical Research (CRC Press, 1991).
26. Yukl, S.A. et al. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J. Infect. Dis. 208, 1212-1220 (2013).
27. Perreau, M. and Kremer, E.J. Frequency, proliferation and activation of human memory T cells induced by a nonhuman adenovirus. J. Virol. 79, 14595-14605 (2005).
28. Pantaleo, G. et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88, 9838-9842 (1991).
29. Vandergeeten, C. et al. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood 121, 4321-4329 (2013).